abstract |
The present invention is generally related to the treatment or prevention of diseases associated with angiogenesis through administering to a patient compounds that have been found to inhibit or substantially reduce angiogenesis. Compounds employed according to the present invention exhibit good anti-angiogenic activity as well as demonstrates a prophylactic effect for the prevention and substantial reduction of angiogenesis. Examples of such compounds include Ritanserin, Amiodarone, Terfenadine, Perfenazine, Bitionol and Clomipramine. |